DINSMORE CHRISTOPHER (Chief Scientific Officer) sold 2.3% of their position (6.63K shares) of KRONOS BIO, INC. on the open market
Open‑market sale worth $11.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/7/2023ACC: 0001209191-23-041789
Officer· Chief Scientific Officer
Since Oct 2020
-6.63K
Net shares
Net seller
$11.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.63K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.63K
Price / share
$1.75
Trade value
$11.62K
% of position
2.3%
7/6/2023
285K→278.37K
Total
Net shares
−6.63K
Net value
-$11.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/6/2023 | S · Sale | −6.63K | $1.75 | $11.62K | 2.3% | 285K | 278.37K |
| Total | −6.63K | -$11.62K | ||||||
Derivative Transactions0
No derivative transactions reported